Global Market Study on Rheumatoid Arthritis Diagnosis Test: Commercialization of Novel Rapid Test Kits Underway


Rheumatoid Arthritis  Market
  • Published On : Sep-2019 |
  • Pages : 162 Pages |
  • Format :

Rheumatoid arthritis (RA) is highly prevalent in North America and some European countries. According to the report published by Centre of Disease control and Prevention (CDC) in 2018, approximately 54 million adults suffered from rheumatoid arthritis in the U.S. Such high prevalence of RA requires effective diagnosis and treatment solutions. Thus, the rheumatoid arthritis diagnosis test market is expected to witness substantial growth in the global market in the forecast period.

Currently, the prevalence of rheumatoid arthritis is relatively low in developing countries. However, the rising number of geriatric population especially in China and Japan, is estimated to increase in the prevalence of rheumatoid arthritis in the forecast period. This increasing prevalence of rheumatoid arthritis and other orthopedic disorders is expected to lead to a rise in demand for rheumatoid arthritis test kits across the Asia Pacific region, thus leading to the growth of the rheumatoid arthritis diagnosis test market.

global rheumatoid arthritis diagnosis test market

Widespread Availability of Rheumatoid Arthritis Diagnostic Test Kits

Companies manufacturing rheumatoid arthritis diagnosis test kits are targeting the global market through their strong distribution network, thus making the product available at each level of value chain. Manufacturers are focusing on the distribution agreement and partnership with local distributors and manufacturing companies to cater to the increasing need for rheumatoid arthritis diagnosis test kits.

Currently, the rheumatoid arthritis diagnostic test market in the Asia Pacific region is being dominated by the off-label diagnosis procedures such as RF test, ESR test, uric acid test, and others, which have limited specificity and sensitivity. However, Anti–cyclic citrullinated peptide (anti–CCP) test and antinuclear antibody (ANA) test segments are anticipated to lead the market growth owing to their high specificity and sensitivity. Thus, wide availability of these rheumatoid arthritis diagnosis test kits is propelling the growth of the rheumatoid arthritis diagnosis test market.

Commercialization of Rapid Diagnostic Test Kits to Fuel the Market Growth

Increasing incidences of rheumatoid arthritis and other autoimmune diseases have created a need for rapid rheumatoid arthritis diagnostic test solutions, which would reduce the time and efforts required during sample testing. Thus, rheumatoid arthritis diagnosis test kits manufacturers are focusing on the commercialization of novel rapid diagnostic test kits, which have high specificity and sensitivity.

The commercialization of rapid diagnostic test kits is anticipated to increase its demand as well as increase the efficacy of rheumatoid arthritis treatment monitoring test kits. The introduction of these rapid rheumatoid arthritis diagnosis test kits is contributing to the growth of the rheumatoid arthritis diagnosis test market.

Adoption of Minimally Invasive Rheumatoid Arthritis Diagnosis Test

There is a rise in incidences of rheumatoid arthritis among European and North American children. This increasing overall incidence rate, calls for adoption of minimally invasive test method to diagnose rheumatoid arthritis. Hence, there is a high demand for rheumatoid arthritis diagnosis test kits with minimally invasive testing method in these regions, spurring the growth of the overall rheumatoid arthritis diagnosis test market.

Commercialization of cost effective drugs to treat rheumatoid arthritis is expected to promote the growth of the rheumatoid arthritis diagnosis test market, as these medications require continuous monitoring of patients. Moreover, it will help to promote the adoption of novel test methods used in the early diagnosis of rheumatoid arthritis. Hence, commercialization of drugs could have a direct impact on the growth of the rheumatoid arthritis diagnosis test market.

Analysts’ Viewpoint

A comprehensive view of the rheumatoid arthritis diagnosis test market has led our analysts to conclude that, the market is growing at an impressive rate, with Asia Pacific and Europe holding a large chunk of the global demand for rheumatoid arthritis diagnosis test kits. Increasing adoption of rheumatoid arthritis diagnosis test kits, especially in developed countries, such as the U.S, Mexico, and Germany, is spurring the growth of the global rheumatoid arthritis diagnosis test market.

The rheumatoid arthritis diagnosis test market is expected to have a robust growth in the forecast period in countries of the Latin American region. This is attributed to the rising prevalence of rheumatoid arthritis among adult population in the region and also due to the improving healthcare facilities in countries such as Brazil and Mexico, thus contributing to the growth of the rheumatoid arthritis diagnosis test market.

Moreover, increasing demand for rapid rheumatoid arthritis diagnosis test kits is anticipated to create more opportunities for rheumatoid arthritis diagnosis test market players. In addition, the development of novel biomarker test methods is expected to surge the growth of the rheumatoid arthritis diagnosis test market. However, factors such as limited specificity and sensitivity of rheumatoid arthritis diagnosis test kits and lack of effective drug treatment are projected to deter the growth of the rheumatoid arthritis diagnosis test market.

Persistence Market Research (PMR) recently published a market study on the global market for rheumatoid arthritis diagnosis test. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the rheumatoid arthritis diagnosis test market structure. Market study presents exclusive information about how the rheumatoid arthritis diagnosis test market will grow during the forecast period 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the rheumatoid arthritis diagnosis test market in the forecast period.

The study is relevant for stakeholders in the rheumatoid arthritis diagnosis test market, including rheumatoid arthritis diagnosis test manufactures suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the rheumatoid arthritis diagnosis test market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macro and microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the rheumatoid arthritis diagnosis test market. Furthermore, small businesses and new entrants in the rheumatoid arthritis diagnosis test market too can make use of the information presented in this study, based on, which they can make appropriate business decisions in order to gain momentum in the rheumatoid arthritis diagnosis test market.

Key Segments of Rheumatoid Arthritis Diagnosis Test Market

PMR’s study on the rheumatoid arthritis diagnosis test market offers information divided into four important segments— diagnostic test type, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Diagnostic Test Type

End User

 Region

  • Serology Tests
    • Erythrocyte Sedimentation Rate (ESR) through lens Loupes
    • Rheumatoid Factor (RF)
    • Anti–cyclic Citrullinated Peptide (anti–CCP)
    • Antinuclear Antibody (ANA)
    • Uric Acid
    • Other Tests
  • Monitoring RA Treatment Efficiency Tests
    • Salicylate Level Count
    • Muscle Enzyme Tests
    • Creatinine Test

 

  • Hospitals
  • Diagnostic Laboratories
    • Private Laboratories
    • Public Laboratories
  • Ambulatory Surgical Centers
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Questions Answered in PMR’s Rheumatoid Arthritis Diagnosis Test Market Report

  • Which regions will continue to remain the most profitable regional markets for rheumatoid arthritis diagnosis test market players?
  • Which factors will induce a change in the demand for rheumatoid arthritis diagnosis test in the assessment period?
  • How will changing trends impact the rheumatoid arthritis diagnosis test market?
  • How can market players capture the low-hanging opportunities in the rheumatoid arthritis diagnosis test in developed regions?
  • Which companies are leading the rheumatoid arthritis diagnosis test market?
  • What are the winning strategies of stakeholders in the rheumatoid arthritis diagnosis test market to upscale their position in this landscape?

Rheumatoid Arthritis Diagnosis Test Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the rheumatoid arthritis diagnosis test market, and reach to conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to analysts during the production of the rheumatoid arthritis diagnosis test market study, include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the rheumatoid arthritis diagnosis test market, and makes PMR’s projection on the growth prospects of the rheumatoid arthritis diagnosis test market more accurate and reliable.

Company Profiles:

  • Abbott Diagnostics
  • Antibodies Incorporated
  • Beckman Coulter, Inc.
  • Euro Diagnostica AB
  • Thermo Fisher Scientific Inc. 
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
Back To Top